range of pharmaceutical and related health care products

McKesson has been awarded a Texas contract (HHSTX-7-0000410503) effective July 28, 2026, for the supply of pharmaceutical and related health care products. The contract encompasses a range of allergenic extract preparations and specialized pharmaceutical preparations classified under the Miscellaneous Drugs and Pharmaceuticals category (NIGP 26972). The scope of supply includes alfalfa allergenic extract, horse epithelium allergenic extract, rabbit epithelium allergenic extract, and alder allergenic extract, which are utilized in diagnostic and therapeutic applications for allergic conditions.

In addition to the allergenic extract products, McKesson's contract includes supply of fecal microbiota transplant preparation, representing specialized pharmaceutical therapeutics for gastrointestinal and related clinical applications. While specific contract values, performance locations, and detailed contract duration are not provided in the available documentation, the award confirms McKesson as the prime contractor responsible for fulfillment of the specified pharmaceutical and health care product deliverables to the State of Texas.